placebo for abatacept injection, 125 mg/syringe, Abatacept clinical trials

A Randomized Double-Blind, Placebo Controlled Trial of Abatacept (CTLA4-Ig) in Giant Cell Arteritis (ABAGART)

This study is looking into a new medicine called abatacept for a condition called Giant Cell Arteritis (GCA). We want to see if abatacept can help people stay well without symptoms compared to a dummy medicine, focusing on how patients feel and their safety over 12 months.